Pimecrolimus

FDA Approved: * December 27, 2018
Pharm Company: * ACTAVIS LABS UT INC
Category: Skin Care

Pimecrolimus is an immunomodulating agent[clarification needed] of the calcineurin inhibitor class used in the treatment of atopic dermatitis (eczema). It is available as a topical cream, once marketed by Novartis (however, Galderma has been promoting the compound in Canada since early 2007) under the trade name Elidel. Contents 1 Medical uses 2 Side effects 3 Pharmacology 4 References 5 External links Medical uses It has been proven to be effective in various inflammat... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Pimecrolimus 10 mg/g Topical Cream
NDC: 0591-2944
Labeler:
Actavis Pharma, Inc.
Pimecrolimus 10 mg/g Topical Cream
NDC: 68462-609
Labeler:
Glenmark Pharmaceuticals Inc., USA
Pimecrolimus 10 mg/g Topical Cream
NDC: 68682-110
Labeler:
Oceanside Pharmaceuticals
Pimecrolimus 10 mg/g Topical Cream
NDC: 68682-111
Labeler:
Oceanside Pharmaceuticals
Pimecrolimus 10 mg/g Topical Cream
NDC: 68682-112
Labeler:
Oceanside Pharmaceuticals
Pimecrolimus 10 mg/g Topical Cream
NDC: 70518-2292
Labeler:
Remedyrepack Inc.

Related Brands

Drugs with the same active ingredients